Form 4 for PRTA PROTHENA CORP PUBLIC LTD CO
Accepted 2023-03-22 00:00:00 ET · period of report 2023-03-20 · accession 0001140361-23-013190 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-22 | 2023-03-20 | PRTA | Walker Karin L | CAO | S - Sale+OE | $47.72 | -5,000 | 0 | -100% | -$238.6K |
| D | 2023-03-22 | 2023-03-20 | PRTA | Walker Karin L | CAO | M - OptEx | $15.04 | +5,000 | 5,000 | New | +$75.2K |
| D | 2023-03-22 | 2023-03-20 | PRTA | Walker Karin L | CAO | M - OptEx | $0.00 | -5,000 | 30.5K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value $0.01 per share | 2023-03-20 | S | D | 3,903 | $47.51 | 1,097 | D | — | — | (F2) The transaction was executed in multiple trades in prices ranging from $47.305 to $48.22, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4. |
| 2 | Common | Ordinary Shares, par value $0.01 per share | 2023-03-20 | M | A | 5,000 | $15.04 | 5,000 | D | — | — | |
| 3 | Common | Ordinary Shares, par value $0.01 per share | 2023-03-20 | S | D | 1,097 | $48.47 | 0 | D | — | — | (F3) The transaction was executed in multiple trades in prices ranging from $48.33 to $48.73, inclusive. |
| 4 | Derivative | Stock Option (right to buy) | 2023-03-20 | M | D | 5,000 | $0.00 | 30,481 | D | $15.04 · — to 2028-06-21 | 5,000 Ordinary Shares | (F5) The Reporting Person's prior Form 4 filed on March 17, 2023 inadvertently transposed the first two digits of the number of options reported in Column 9, reporting 53,481 options beneficially owned following the Reporting Person's transaction in these options on March 15, 2023, instead of the correct number of 35,481 options beneficially owned. The correct number of 35,481 options beneficially owned was used for purposes of calculating the number of options reported in Column 9 of this Form 4. (F4) The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on June 21, 2019, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. |